Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
0.1938
+0.0096 (5.21%)
Apr 23, 2025, 4:00 PM EDT - Market closed

Ernexa Therapeutics Market Cap

Ernexa Therapeutics has a market cap or net worth of $10.13 million as of April 23, 2025. Its market cap has decreased by -14.92% in one year.

Market Cap
10.13M
Enterprise Value
9.08M
1-Year Change
-14.92%
Ranking
Category
Stock Price
$0.19

Market Cap Chart

Since December 1, 1998, Ernexa Therapeutics's market cap has decreased from $21.10M to $10.13M, a decrease of -52.01%. That is a compound annual growth rate of -2.74%.

History

DateMarket Cap% Change
Apr 22, 20259.60M-36.42%
Dec 31, 202415.10M55.67%
Dec 29, 20239.70M2.11%
Dec 30, 20229.50M-95.62%
Dec 31, 2021217.00M3,187.88%
Dec 31, 20206.60M3.13%
Dec 31, 20196.40M14.29%
Dec 31, 20185.60M-47.17%
Dec 29, 201710.60M-44.79%
Dec 30, 201619.20M29.73%
Dec 31, 201514.80M-63.55%
Dec 31, 201440.60M-10.18%
Dec 31, 201345.20M203.36%
Dec 31, 201214.90M-1.97%
Dec 30, 201115.20M-34.20%
Dec 31, 201023.10M-15.07%
Dec 31, 200927.20M262.67%
Dec 31, 20087.50M-78.07%
Dec 31, 200734.20M-54.22%
Dec 29, 200674.70M-6.74%
Dec 30, 200580.10M-52.55%
Dec 31, 2004168.80M-3.87%
Dec 31, 2003175.60M272.03%
Dec 31, 200247.20M42.17%
Dec 31, 200133.20M52.29%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 735.68B
UnitedHealth Group 394.34B
Johnson & Johnson 376.90B
AbbVie 300.07B
Novo Nordisk 284.50B
Abbott Laboratories 223.73B
Novartis AG 209.93B
AstraZeneca 208.11B
Market Cap Rankings